Key Points
- Risks of soft tissue augmentation
- Proper placement of injectable fillers
- Preventing infection, necrosis
Englewood, Colo. — Soft tissue augmentation using injectable fillers has an outstanding safety profile overall. However, minimizing the risk
of complications requires that surgeons be knowledgeable about the material they are injecting. Additionally, they must be
knowledgeable about the local anatomy and proper injection technique, according to Joel L. Cohen, M.D., director of AboutSkin
Dermatology and DermSurgery in Englewood and Lone Tree, Colo., and volunteer clinical assistant professor of dermatology,
University of Colorado.
"Thousands of patients are receiving filler injections on a daily basis, and serious complications are rare," Dr. Cohen says.
"However, it is important to know what can go wrong because it provides insight for understanding preventive strategies, but
also to be familiar with techniques for managing complications if they arise."
Placement issues
Inappropriate placement — usually injection too superficially — is one of the most common reasons for patient dissatisfaction
after a filler procedure. With hyaluronic acid products, it can result in not only visible product lumps or ridges, but also
a blue-gray discoloration (Tyndall effect). Visible filler
Avoidance through use of proper injection technique is the best approach to management. However, when filler is visible under
the skin, it can sometimes be addressed with massage, aspiration, incision and drainage, or if the product is a hyaluronic
acid, hyaluronidase (Amphadase, Amphastar Pharmaceuticals; Vitrase, ISTA Pharmaceuticals; and compounded sources) can be injected
to dissolve the filler.
Too superficial placement of a non-hyaluronic acid product, i.e., porcine collagen (Evolence, Ortho Dermatologics) and calcium
hydroxylapatite (Radiesse, BioForm Medical), can result in the appearance of white nodules.
This problem can be avoided by injecting these materials into the subcutaneous space rather than the dermis, and can be treated
by expressing the contents of the nodule through a puncture site created with a No. 11 blade or an 18-gauge needle.
"When calcium hydroxylapatite was used by some physicians several years ago for lip augmentation, and even if it was injected
into the proper deep plane, visible nodules seemed to occur as the material was seemingly forced toward the surface by the
pumping action of the orbicularis oris muscle.
"It is for this reason that calcium hydroxylapatite is no longer recommended for injection in the lips," Dr. Cohen says.
Fibrotic response
Dr. Cohen also points out that surgeons may see patients who have been treated with the permanent product Artefill (Suneva
Medical) or its predecessor, Artecoll (which was used in Canada and other countries), present with a fibrotic response associated
with too superficial placement.
Management of this hypertrophic scarring-type reaction can be approached with topical or intralesional steroids or a pulsed
dye laser.
Superficial placement of these permanent products has also been associated with itching and redness that may be managed with
topical or intradermal corticosteroids.
Acute reactions
Bruising and swelling represent postinjection sequelae rather than true complications, but for the cosmetic surgery patient,
they are disturbing events that can affect satisfaction.
Counseling patients to withhold medications and supplements that can interfere with coagulation is one strategy for minimizing
these postoperative reactions, and there is a long list of potential culprits, including NSAIDs, various vitamins and nutritional
supplements, and even horseradish.
However, Dr. Cohen notes that he does not stop warfarin, aspirin, or clopidogrel (Plavix, Bristol-Myers Squibb) that is being
taken for therapeutic reasons, since the consequences of a cardiac or cerebrovascular event far outweigh that of post-treatment
bruising.
Studies
Results of a double-blind controlled study performed by Dr. Cohen showed a benefit for vitamin K oxide gel (Auriderm, Biopelle)
in hastening the resolution of purpura after pulsed dye laser treatment.
"I have all my filler patients use this product, and recommend applying it four to five times a day," says Dr. Cohen.
Results of a study in which Dr. Cohen participated evaluating patients treated with Perlane and Restylane (hyaluronic acid,
Medicis) showed that rapid injection, 0.3 cc/min or faster, and use of a fanning injection technique increased the likelihood
of bruising and swelling (Dermatol Surg. 2008;34 (Suppl1):S105-S109).
"Surprisingly, the gauge of the needle used for the injection did not affect the risk of these events," Dr. Cohen says.